Study to evaluate immunogenicity of the hepatitis B antigen of the GSK Biologicals’ candidate malaria vaccine (257049)

Trial Identifier:	113681
Sponsor:	GlaxoSmithKline
NCTID::	NCT01345240
Start Date:	November 2011
Primary Completion Date:	January 2013
Condition:	Parasite Infections

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

	For Burkina Faso

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Burkina Faso	Ouagadougou 01, Burkina Faso
Ghana	Kumasi, Ghana

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.